Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
about
SR-2P vaginal microbicide gel provides protection against herpes simplex virus 2 when administered as a combined prophylactic and postexposure therapeuticChitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.
P2860
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prophylactic treatment with a ...... protects from HSV-2 infection.
@ast
Prophylactic treatment with a ...... protects from HSV-2 infection.
@en
Prophylactic treatment with a ...... protects from HSV-2 infection.
@nl
type
label
Prophylactic treatment with a ...... protects from HSV-2 infection.
@ast
Prophylactic treatment with a ...... protects from HSV-2 infection.
@en
Prophylactic treatment with a ...... protects from HSV-2 infection.
@nl
prefLabel
Prophylactic treatment with a ...... protects from HSV-2 infection.
@ast
Prophylactic treatment with a ...... protects from HSV-2 infection.
@en
Prophylactic treatment with a ...... protects from HSV-2 infection.
@nl
P2860
P356
P1476
Prophylactic treatment with a ...... protects from HSV-2 infection
@en
P2093
Carsten Alt
P2860
P304
P356
10.1093/JAC/DKU318
P407
P577
2014-08-19T00:00:00Z